MUFG Securities EMEA’s AbbVie ABBV Stock Holding History

MUFG Securities EMEA’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-250,000	Closed	-$14.6M	–	111
2015 Q1	$14.6M	Buy	+250,000	New	+$15.1M	3.8%	7

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

MUFG Securities EMEA's ABBV Position: Q1 2026 in Review

MUFG Securities EMEA increased its AbbVie (ABBV) stake by 497% in Q1 2026, buying an estimated $79.9M and bringing the position to 432,445 shares worth $94.1M. The position accounts for 1.4% of the portfolio, ranked #18.

MUFG Securities EMEA first reported a position in ABBV in Q2 2015 and has held it in 22 quarters since. 4,077 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

MUFG Securities EMEA held 432,445 shares of AbbVie worth $94.1M as of Q1 2026.
MUFG Securities EMEA bought 360,000 AbbVie shares in Q1 2026, an estimated $79.9M.
AbbVie made up 1.4% of MUFG Securities EMEA's portfolio in Q1 2026, its #18 holding.
MUFG Securities EMEA first reported a position in AbbVie in Q2 2015 and has held it in 22 quarters since.
4,077 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on MUFG Securities EMEA's 13F filing for Q1 2026, filed 11 May 2026.